HutchMed (China), in which Hong Kong conglomerate CK Hutchison Holdings holds a major stake, is poised to market its self-developed cancer drug “fruquintinib” in Japan and Europe, according to ...
An FDA panel is urging Acrotech Biopharma to accelerate research into the efficacy of two blood cancer drugs brought to market via the agency's accelerated approval pathway. The FDA's Oncologic ...
Nov 15 (Reuters) - The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb's (BMY.N) lung cancer drug that was acquired as part of the company's $4.1 billion buyout of ...
A year after the FDA found shredded quality documents at an Intas Pharmaceuticals drug manufacturing facility in India, Intas' parent company Accord Healthcare resumed making cisplatin, which has ...
The US Food and Drug Administration (FDA) has approved Takeda’s Fruzaqla (fruquintinib) for patients with metastatic colorectal cancer (mCRC) who have undergone previous treatment. The oral ...
The Food and Drug Administration (FDA) is investigating cinnamon apple puree and applesauce products amid reports of elevated blood lead levels in at least 34 individuals. Residents in more than ...
The most common type of breast cancer now has a new targeted treatment: an AstraZeneca drug that’s first in a new class of therapies addressing a certain genetic signature. But the new approval ...
Nov 16 (Reuters) - The U.S. Food and Drug Administration on Thursday approved AstraZeneca's (AZN.L) Truqap in combination with an older drug, providing another treatment option for patients with ...
The FDA White Oak Campus, headquarters of the United States Food and Drug Administration (FDA), a federal agency of the Department of Health and Human Services (HHS). Credit - Getty Images The ...
